Chancery Approves Bioscience Co. Deal, Splits $850K Fees
A Selecta Biosciences stockholder who sought 40% of a proposed $850,000 fee award for a $6.7 million settlement the company brokered with another stockholder convinced a Delaware Chancery Court judge on...To view the full article, register now.
Already a subscriber? Click here to view full article